{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:33:43Z","timestamp":1771353223057,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.nec.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T21:18:32Z","timestamp":1537046312000},"page":"493-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetics of Hypercoagulable and Hypocoagulable States"],"prefix":"10.1016","volume":"29","author":[{"given":"Daulath","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sucha","family":"Nand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanh P.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nec.2018.06.002_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-9560-4-15","article-title":"Hereditary thrombophilia","volume":"4","author":"Khan","year":"2006","journal-title":"Thromb J"},{"key":"10.1016\/j.nec.2018.06.002_bib2","first-page":"185","article-title":"Thrombosis and thrombophilia","volume":"2016","author":"Garcia","year":"2016","journal-title":"Am Soc Hematol Self-Assess Program"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.pop.2016.07.001","article-title":"Thrombosis, hypercoagulable states, and anticoagulants","volume":"43","author":"Hollenhorst","year":"2016","journal-title":"Prim Care"},{"issue":"10","key":"10.1016\/j.nec.2018.06.002_bib4","first-page":"1095","article-title":"Screening for inherited thrombophilia: indications and therapeutic implications","volume":"87","author":"De Stefano","year":"2002","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.nec.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1538-7836.2004.00863.x","article-title":"Inherited thrombophilia and life-time risk of venous thromboembolism: is the burden reducible?","volume":"2","author":"De Stefano","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.nec.2018.06.002_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1650638","article-title":"Inherited thrombophilia: part 1","volume":"76","author":"Lane","year":"1996","journal-title":"Thromb Haemost"},{"issue":"5 Pt 1","key":"10.1016\/j.nec.2018.06.002_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1164\/ajrccm.158.5.9712022","article-title":"Hereditary thrombophilia and venous thromboembolism","volume":"158","author":"Murin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.nec.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V87.9.3531.bloodjournal8793531","article-title":"Inherited thrombophilia: pathogenesis, clinical syndromes, and management","volume":"87","author":"De Stefano","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1756-185X.12438","article-title":"Antiphospholipid syndrome: 30 years and our contribution","volume":"18","author":"Koike","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.nec.2018.06.002_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1529-0131(199906)42:6<1189::AID-ANR15>3.0.CO;2-8","article-title":"Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"42","author":"Gushiken","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.nec.2018.06.002_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ard.2008.094367","article-title":"STAT4 single nucleotide polymorphism, rs7574865 G\/T, as a risk for antiphospholipid syndrome","volume":"68","author":"Horita","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.33340","article-title":"Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events","volume":"64","author":"Otomo","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood-2007-01-066043","article-title":"Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study","volume":"110","author":"Galli","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/asheducation.V2014.1.531.3883265","article-title":"New insights into genotype and phenotype of VWD","volume":"2014","author":"Flood","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","article-title":"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI exome sequencing project","volume":"122","author":"Johnsen","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"issue":"33","key":"10.1016\/j.nec.2018.06.002_bib20","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bi00215a036","article-title":"Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction","volume":"30","author":"Mancuso","year":"1991","journal-title":"Biochemistry (Mosc)"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jth.12093","article-title":"Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 genomes","volume":"11","author":"Wang","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.nec.2018.06.002_bib23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.nec.2018.06.002_bib24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"21","key":"10.1016\/j.nec.2018.06.002_bib25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.nec.2018.06.002_bib26","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2013-06-498303","article-title":"von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","volume":"122","author":"Lillicrap","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.nec.2018.06.002_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng749","article-title":"Replication validity of genetic association studies","volume":"29","author":"Ioannidis","year":"2001","journal-title":"Nat Genet"},{"issue":"18","key":"10.1016\/j.nec.2018.06.002_bib28","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2009-12-261131","article-title":"Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease","volume":"116","author":"Othman","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2011.02569.x","article-title":"C1272F: a novel type 2A von Willebrand\u2019s disease mutation in A1 domain; its clinical significance","volume":"18","author":"Woods","year":"2012","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.nec.2018.06.002_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.nec.2018.06.002_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ng.249","article-title":"Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci","volume":"40","author":"Cooper","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.nec.2018.06.002_bib32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2516.2008.01966.x","article-title":"Contribution of genetical analysis for diagnosis of von Willebrand\u2019s disease type 2B","volume":"15","author":"Victor","year":"2009","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A\u00a0quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.nec.2018.06.002_bib34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1538-7836.2010.03796.x","article-title":"Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire","volume":"8","author":"Biss","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"10.1016\/j.nec.2018.06.002_bib35","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A\u00a0laboratory phenotype\/genotype correlation of 1167 french patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.nec.2018.06.002_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281031","article-title":"The international society on thrombosis and haematosis von Willebrand disease database: an update","volume":"37","author":"Hampshire","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.nec.2018.06.002_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-08-173278","article-title":"A\u00a0novel deletion mutation is recurrent in von Willebrand disease types 1 and 3","volume":"114","author":"Sutherland","year":"2009","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.nec.2018.06.002_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","article-title":"Genetic diagnosis of haemophilia and other inherited bleeding disorders","volume":"12","author":"Peyvandi","year":"2006","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/asheducation-2014.1.355","article-title":"Lasting power of new clotting proteins","volume":"2014","author":"Powell","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"10.1016\/j.nec.2018.06.002_bib40","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States. The hemophilia surveillance system project investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"issue":"5992","key":"10.1016\/j.nec.2018.06.002_bib42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.blre.2016.08.003","article-title":"Genetic diagnosis in hemophilia and von Willebrand disease","volume":"31","author":"Swystun","year":"2017","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2516.2008.01868.x","article-title":"Introns\u00a01 and 22 inversions and factor VIII inhibitors in patients with severe haemophilia A in southern Brazil","volume":"15","author":"Leiria","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.nec.2018.06.002_bib46","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: molecular pathogenesis and mutation analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"14","key":"10.1016\/j.nec.2018.06.002_bib47","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/bi00335a049","article-title":"Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)","volume":"24","author":"Yoshitake","year":"1985","journal-title":"Biochemistry (Mosc)"},{"issue":"7","key":"10.1016\/j.nec.2018.06.002_bib48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mgg3.30","article-title":"The CDC Hemophilia B mutation project mutation list: a new online resource","volume":"1","author":"Li","year":"2013","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.nec.2018.06.002_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/mp.55.1.1","article-title":"Haemophilia A and haemophilia B: molecular insights","volume":"55","author":"Bowen","year":"2002","journal-title":"Mol Pathol"},{"issue":"4","key":"10.1016\/j.nec.2018.06.002_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.23645","article-title":"Mutation analysis of a cohort of US patients with hemophilia B","volume":"89","author":"Li","year":"2014","journal-title":"Am J Hematol"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368018308659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368018308659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:00:40Z","timestamp":1760904040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368018308659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1042368018308659"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2018.06.002","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Hypercoagulable and Hypocoagulable States","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}